Wound Management Technologies, Inc. - PINK: WNDM
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market.
Wound Management Technologies, Inc. develops, markets, and distributes collagen-based wound care products to physicians, clinics, and hospitals in the United States.
The company offers CellerateRX, a medical device for use on acute and chronic wounds in gel and powder form. It also holds patents for a resorbable bone wax and delivery system for orthopedic bone void fillers.
The company was formerly known as MB Software, Inc. and changed its name to Wound Management Technologies, Inc. in May 2008. Wound Management Technologies, Inc. was founded in 1982 and is based in Addison, Texas.
Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B.
Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development.